No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 20 of the 40 quarters in the window, leaving 20 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 0.7x · 10Y median 2.6x · 6th percentile · as of Oct 5, 2026
Annualized revenue (TTM) · by quarter, last 37
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T12:25:42.980Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for BioHarvest Sciences Inc. (BHST) stock was $1.47 as of Oct 5, 2026, 4:00 PM EDT, down 0.34% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -83.1%
BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services.
Agricultural - Commodities/Milling · Vancouver, BC
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 12, 2026
37 days away
EPS Estimate
-0.16
Revenue Est.
$9.31M
Last Quarter Results
EPS
$-0.17
vs Estimate
$-0.12
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BHST | $25.39M | $1.47 | -0.34% | -83.09% | N/A | N/A | N/A |
| 2APWC | $27.93M | $1.35 | +2.65% | -34.48% | -14.75% | -5.15% | vs BHST |
| 3PSHG | $21.13M | $1.70 | +0.59% | +0.00% | -51.94% | -75.76% | vs BHST |
| 4CVV | $29.71M | $4.28 | -1.15% | +27.61% | -1.26% | -6.82% | vs BHST |
| 5GTEC | $21.05M | $0.79 | -2.09% | -41.10% | -33.89% | N/A | vs BHST |
| 6CLIR | $20.81M | $3.30 | -5.98% | -61.36% | -29.91% | -25.28% | vs BHST |
forward FY estimate
N/A
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$8.84M
vs Estimate
$9.45M
Consensus Rating
Based on 4 analysts
Average Price Target
$10.50
+616.7% upside
Low
$5.00
Current
$1.47
High
$15.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.15 | $-0.14 | $-0.12 | 3 |
| Quarter ending Dec 2026 | $-0.12 | $-0.12 | $-0.11 | 3 |
| Quarter ending Mar 2027 | $-0.13 | $-0.12 | $-0.12 | 1 |
| Quarter ending Jun 2027 | $-0.11 | $-0.11 | $-0.10 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.54 | $-0.53 | $-0.52 | 3 |
| FY 2027 | $-0.34 | $-0.34 | $-0.33 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $8.55M | $9.31M | $10.06M | 3 |
| Quarter ending Dec 2026 | $10.34M | $10.77M | $11.18M | 3 |
| Quarter ending Mar 2027 | $9.76M | $10.21M | $10.55M | 1 |
| Quarter ending Jun 2027 | $10.49M | $10.98M | $11.34M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $37.05M | $37.42M | $37.78M | 3 |
| FY 2027 | $46.74M | $49.59M | $52.44M | 3 |
